Recordati: ISU Belfast urology meeting sponsorship criticised due to overall impression of luxury venue and social programme (Clause 9.1 breach)

📅 2012 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2561/11/12
ComplainantAnonymous group of NHS health professionals (non-contactable)
CompanyRecordati (Recordati Pharmaceuticals Ltd / Recordati Ireland Ltd referenced)
IssueSponsorship/exhibiting at ISU annual meeting; alleged excessive hospitality due to luxury venue and social/leisure programme (golf, gala dinner)
MeetingIrish Society of Urology (ISU) annual meeting, Belfast, Northern Ireland, September 2012 (Culloden Estate and Spa)
Applicable Code year2012
Complaint received4 December 2012
Case completed20 February 2013
AppealNo appeal
Breach foundClause 9.1
No breachClauses 2 and 19.1
SanctionsUndertaking received

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous, non-contactable group describing themselves as NHS health professionals complained about multiple companies’ support of the Irish Society of Urology (ISU) annual meeting held in Belfast, Northern Ireland (September 2012).
  • The complaint focused on the meeting programme’s emphasis on a luxurious 5-star venue (Culloden Estate and Spa), prominent social messaging, and scheduled leisure activities (golf and a gala dinner at Stormont).
  • Recordati Pharmaceuticals Ltd (UK) said no-one from the UK company attended; Recordati Ireland Ltd attended as an exhibitor.
  • The Panel noted the meeting took place in Northern Ireland, so the ABPI Code applied, and UK companies can be responsible for overseas affiliates’ activities when carried out in the UK or relating to UK health professionals.
  • The Panel considered the overall impression created by the programme and sponsorship listings: it was not clear what each company supported, and it could reasonably be assumed listed companies supported everything in the programme (including golf and gala dinner).
⚖️

Outcome

  • Breach: Clause 9.1
  • No breach: Clauses 2 and 19.1
  • The Panel ruled that, taking all circumstances into account, the arrangements as described in the programme and the impression given were unacceptable and high standards had not been met (Clause 9.1).
  • The Panel ruled no breach of Clause 19.1 for Recordati because it had not sponsored any health professional to attend (no accommodation, subsistence or registration fees paid), and the venue was considered on the limits of acceptability but did not lead to a Clause 19.1 breach in this case.
  • The Panel ruled no breach of Clause 2 (particular censure) as the circumstances did not warrant it.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training